A good prescriber will check for personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, pancreatitis, or severe gastrointestinal conditions
The company released Phase 2 clinical data for ASC30, a subcutaneous depot GLP-1 receptor agonist designed to dramatically reduce dosing frequency compared with current therapies
A 2023 analysis published in the *Journal of the American Medical Association* (JAMA) examined compounded semaglutide products and found that approximately 40% contained impurities, incorrect concentrations, or failed sterility testing
The product is a compact pocket-sized shot driven by a hefty hit of protein, chicory root fiber, and a precise mix of vitamins and minerals
This test is part of our comprehensive lab testing menu, available at Quest Diagnostics locations nationwide